PSA Standardization

In this presentation:

Our speaker for this program is Amy K. Saenger, PhD, Director of the Central Clinical Laboratory in the Department of Laboratory Medicine & Pathology at Mayo Clinic in Rochester, Minnesota. Dr. Saenger will provide an overview of the methods available for evaluating prostate-specific antigen (PSA) levels and discuss the clinical implications of standardizing PSA methods.

Closed Captioning is available for this program. Click the CC box in the lower right to turn on the captions.

View the presentation

Viewing Tips

• Before viewing, print the user-friendly Notes Pages.
• After viewing, obtain a Record of Viewing.

Related Tests

• #82023 Prostate-Specific Antigen (PSA), Screen, Serum
• #9284 Prostate-Specific Antigen (PSA), Serum
• #81944 Prostate-Specific Antigen (PSA), Total and Free, Serum
• #9844 Prostate-Specific Antigen (PSA), Immunoperoxidase Stain

Related Information

• Learn more about Dr. Saenger
• Learn more about the Division of Clinical Core Laboratory Services

Send to a Colleague

We invite you to forward this presentation to a colleague.